Document is current
Any future updates will be listed below
-
Authors
Salami, Kolawole https://orcid.org/0000-0003-3649-6709
Imbault, Nathalie
Erlebach, Aljoscha
Urban, Johanna
Zoglowek, Mike
Tornieporth, Nadia G.
- License Information
-
More Information
Article History
Received: 30 August 2019
Accepted: 4 February 2020
First Online: 13 February 2020
Ethics approval and consent to participate
: No ethical approval was required as the study did not involve any confidential data involving human subjects. However, all surveyed sites consented to their data and the outcome of this survey being shared with interested partners, funding organizations, and for publication.
: All surveyed sites consented to the publication of the outcome of the survey.
: Nathalie Imbault is an employee of CEPI who funds the development of multiple Lassa candidate vaccines. Kolawole Salami had a student internship at CEPI and conducted this study in the framework of his master thesis in Vaccinology and Pharmaceutical Development at the University of Siena, Italy. Johanna Urban, Mike Zoglowek, and Aljoscha Erlebach were master’s degree students of medical information management at the University of Applied Sciences and Arts, Hannover. Nadia Tornieporth is employed by the University of Applied Sciences and Arts, Hannover, and worked for CEPI as a consultant.
